Veltassa

April 21, 2017

Veltassa Normalizes Blood Potassium in Kidney Disease with or Without Food, Trial Shows

News

Veltassa (patiromer) is an effective treatment against hyperkalemia, or excessive levels of potassium in the blood, whether chronic kidney disease (CKD) patients take it with or without food, a clinical ... Read more

September 12, 2016September 12, 2016

Hyperkalemia Treatment, Veltassa, Seen to Work With or Without Food in Phase 4 Study

News

Phase 4 clinical trial results show that Relypsa‘s Veltassa (patiromer), a drug used to treat hyperkalemia (excessive levels of potassium in the blood) — a condition that affects many patients with chronic ... Read more

May 31, 2016May 31, 2016

Relypsa Presents Veltassa Data for Hyperkalemia at 53rd European Renal Association Congress

News

The biopharmacuetical company Relypsa, during the recent 53rd Congress of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), presented new data from studies evaluating the company’s Veltassa (patiromer) for hyperkalemia. “Patients ... Read more

Most Popular CKD Articles This Month